Considering the multitude of functions performed by Ca2+-binding proteins, the structural alterations induced by filling of their Sr2+-selective sites may rationalize the variety of the side effects of strontium ranelate accompanying osteoporosis treatment (see Section 1). This evidence concerns the gene CA2 and osteoporosis.